Australia markets closed

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.0500-0.0500 (-1.61%)
At close: 04:00PM EDT
3.0600 +0.01 (+0.33%)
After hours: 06:48PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-80,951
-110,559
-182,024
-220,683
-227,278
-
Depreciation & amortisation
2,870
2,899
2,889
3,021
2,847
-
Stock-based compensation
28,282
32,854
42,980
46,851
50,218
-
Change in working capital
7,226
16,790
-10,506
-35,079
-13,008
-
Accounts receivable
-13,874
-8,088
-16,550
6,351
-1,971
-
Inventory
9,586
12,463
-6,191
-6,477
-16,937
-
Accounts payable
-3,228
15
-578
3,278
-2,233
-
Other working capital
-44,726
-60,334
-148,737
-206,376
-191,633
-
Other non-cash items
428
339
202
904
1,429
-
Net cash provided by operating activities
-43,405
-58,789
-146,912
-203,354
-184,820
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-1,545
-1,825
-3,022
-6,813
-
Purchases of investments
-111,608
-87,658
-145,683
-129,221
-134,007
-
Sales/maturities of investments
95,355
107,185
143,957
164,940
349,775
-
Net cash used for investing activities
-17,561
17,995
-3,324
32,729
208,955
-
Cash flows from financing activities
Debt repayment
-
-
-
-
0
0
Common stock issued
-
29,755
75,145
0
0
-
Net cash used provided by (used for) financing activities
54,326
54,107
75,059
156,028
9,105
-
Net change in cash
-6,640
13,313
-75,177
-14,597
33,240
-
Cash at beginning of period
27,090
15,364
90,541
105,138
71,898
-
Cash at end of period
20,450
28,677
15,364
90,541
105,138
-
Free cash flow
Operating cash flow
-43,405
-58,789
-146,912
-203,354
-184,820
-
Capital expenditure
-
-1,545
-1,825
-3,022
-6,813
-
Free cash flow
-44,726
-60,334
-148,737
-206,376
-191,633
-